Nantahala Capital Management, LLC

Holdings History for Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Symbol: APRE on Nasdaq
Investment type: Equity / Common stock, par value $0.001 per share
Latest Disclosed Shares Owned: 411,520 shares
Security Ownership %: 4.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Nantahala Capital Management, LLC ownership in Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE)

13 Feb 2026 - Nantahala Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 411,520 shares of Aprea Therapeutics, Inc. Common stock, par value $0.001 per share (APRE). This represents 4.5% ownership of the company. In their previous filing dated 14 Nov 2024, Nantahala Capital Management, LLC had reported owning 411,520 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Nantahala Capital Management, LLC	4.5%	-40%	$386,829	411,520	0		$0.94	13G/A	31 Dec 2025	13 Feb 2026, 17:02
Nantahala Capital Management, LLC	7.3%		$720,160	411,520			$1.75	13G	30 Sep 2024	14 Nov 2024, 16:53

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	0%	$175,513	205,760	0		$0.85	Q4 2025
30 Sep 2025	0.02%	0%	$303,496	205,760	0		$1.48	Q3 2025
30 Jun 2025	0.02%	0%	$347,734	205,760	0		$1.69	Q2 2025
31 Mar 2025	0.03%	0%	$419,750	205,760	0		$2.04	Q1 2025
31 Dec 2024	0.05%	0%	$676,950	205,760	0		$3.29	Q4 2024
30 Sep 2024	0.05%	0%	$565,840	205,760	0		$2.75	Q3 2024
30 Jun 2024	0.08%	0%	$837,443	205,760	0		$4.07	Q2 2024
31 Mar 2024	0.14%	+0.14%	$1,376,534	205,760	+205,760	NEW	$6.69	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.